Nuwellis' Strategic Partner, Seastar Medical, Receives FDA Approvable Letter For Its Pediatric Selective Cytopheretic Device

  • Kevin Chung

Press/Media

Period31 Oct 2023

Media coverage

1

Media coverage

  • TitleNuwellis' Strategic Partner, Seastar Medical, Receives FDA Approvable Letter For Its Pediatric Selective Cytopheretic Device
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date31/10/23
    PersonsKevin Chung
View all 1
View less